Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64

[1]  S. Redwood,et al.  Abrogation of the invasion of human bladder tumor cells by using protease inhibitor(s) , 2010, Cancer.

[2]  R. Khokha,et al.  Fate of melanoma cells entering the microcirculation: over 80% survive and extravasate. , 1995, Cancer research.

[3]  H. Welgus,et al.  Complete degradation of type X collagen requires the combined action of interstitial collagenase and osteoclast-derived cathepsin-B. , 1995, The Journal of clinical investigation.

[4]  Bonnie F. Sloane,et al.  Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. , 1994, The American journal of pathology.

[5]  A. Ferrando,et al.  Human cathepsin O. Molecular cloning from a breast carcinoma, production of the active enzyme in Escherichia coli, and expression analysis in human tissues. , 1994, The Journal of biological chemistry.

[6]  J. Nip,et al.  Paracrine growth stimulation by hepatocyte-derived insulin-like growth factor-1: a regulatory mechanism for carcinoma cells metastatic to the liver. , 1994, Cancer research.

[7]  Motoharu Seiki,et al.  A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.

[8]  N. Gebbia,et al.  Effects of E-64 (cysteine-proteinase inhibitor) and pepstatin (aspartyl-proteinase inhibitor) on metastasis formation in mice with mammary and ovarian tumors. , 1994, In vivo.

[9]  Bonnie F. Sloane,et al.  Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. , 1994, Journal of cell science.

[10]  T. Fox,et al.  Potent slow-binding inhibition of cathepsin B by its propeptide. , 1992, Biochemistry.

[11]  G. Batist,et al.  Eradication of hepatic metastases of carcinoma H-59 by combination chemoimmunotherapy with liposomal muramyl tripeptide, 5-fluorouracil, and leucovorin. , 1992, Cancer research.

[12]  H. Kobayashi,et al.  Modulation of Urokinase-type Plasminogen Activator and Ovarian Cancer Cell Invasion by in Vitro Inhibition of Updated Version Citing Articles E-mail Alerts Inhibition of in Vitro Ovarian Cancer Cell Invasion by Modulation of Urokinase- Type Plasminogen Activator and Cathepsin B , 2022 .

[13]  A. Chambers,et al.  Differences in the repertoires of basement membrane degrading enzymes in two carcinoma sublines with distinct patterns of site-selective metastasis. , 1992, Biochimica et biophysica acta.

[14]  I. Thesleff,et al.  Molecular cloning of murine 72-kDa type IV collagenase and its expression during mouse development. , 1992, The Journal of biological chemistry.

[15]  Bonnie F. Sloane,et al.  Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. , 1992, The Biochemical journal.

[16]  M. Lesser,et al.  Degradation of rat lung collagens by cathepsin B. , 1992, The Journal of laboratory and clinical medicine.

[17]  Bonnie F. Sloane,et al.  A possible role for cysteine proteinase and its inhibitors in motility of malignant melanoma and other tumour cells , 1992, Melanoma research.

[18]  L. Liotta,et al.  Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.

[19]  Bonnie F. Sloane,et al.  Cathepsin B and its endogenous inhibitors: the role in tumor malignancy , 1990, Cancer and Metastasis Reviews.

[20]  R. Hembry,et al.  Metalloproteinases and cancer invasion and metastasis. , 1989, International journal of cancer.

[21]  S. Yagel,et al.  Suppression by cathepsin L inhibitors of the invasion of amnion membranes by murine cancer cells. , 1989, Cancer research.

[22]  Bonnie F. Sloane,et al.  Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants. , 1987, Cancer research.

[23]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[24]  James B. Mitchell,et al.  Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. , 1987, Cancer research.

[25]  D. Rifkin,et al.  Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade , 1986, Cell.

[26]  R. Caccese,et al.  Proteoglycan- and Collagen-Degrading Enzymes from Human Interleukin 1-Stimulated Chondrocytes from Several Species: Proteoglycanase and Collagenase Inhibitors as Potentially New Disease-Modifying Antiarthritic Agents , 1986, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[27]  A. Martinez‐Hernandez.  The hepatic extracellular matrix. I. Electron immunohistochemical studies in normal rat liver. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[28]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[29]  L. Liotta,et al.  Tumor invasion and the extracellular matrix. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[30]  L. Liotta,et al.  Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.

[31]  H. Wexler.  Accurate identification of experimental pulmonary metastases. , 1966, Journal of the National Cancer Institute.

[32]  Bonnie F. Sloane,et al.  Chapter 12 – Regulation of Lysosomal Endopeptidases in Malignant Neoplasia , 1994 .

[33]  J. Wright,et al.  Cysteine proteinase cathepsin L expression correlates closely with the metastatic potential of H-ras-transformed murine fibroblasts. , 1987, Oncogene.

[34]  A. Feinberg,et al.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum. , 1984, Analytical biochemistry.

[35]  A. Barrett,et al.  L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. , 1982, The Biochemical journal.

[36]  A. Barrett,et al.  Cathepsin B, Cathepsin H, and cathepsin L. , 1981, Methods in enzymology.

[37]  Alan J. Barrett,et al.  [41] Cathepsin B, cathepsin H, and cathepsin L , 1981 .

[38]  H Umezawa,et al.  Structures and activities of protease inhibitors of microbial origin. , 1976, Methods in enzymology.

[39]  K. Imahori,et al.  Thiol protease-specific inhibitor E-64 arrests human epidermoid carcinoma A 431 cells at mitotic metaphase ( mitosis / celi cycle / cytoskeleton / Ca 2 +-activated neutral protease ) , 2022 .